CN1120721C - Exterior-applied ointment for treating piles - Google Patents
Exterior-applied ointment for treating piles Download PDFInfo
- Publication number
- CN1120721C CN1120721C CN01114069A CN01114069A CN1120721C CN 1120721 C CN1120721 C CN 1120721C CN 01114069 A CN01114069 A CN 01114069A CN 01114069 A CN01114069 A CN 01114069A CN 1120721 C CN1120721 C CN 1120721C
- Authority
- CN
- China
- Prior art keywords
- piles
- present
- external
- hemorrhoid
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses an external-use ointment for treating piles, which is composed of dandelion, safflower, talcum, frankincense, rhubarb, prepared myrrh, eupolyphaga, dragon blood, notoginseng and borneol which are made into the external-use ointment by a traditional Chinese medicine processing technology. The present invention is characterized in that the present invention is made of pure Chinese herbal medicines and has the functions of activating blood circulation, dissipating blood stasis, clearing heat, removing toxicity, dissipating pain and swelling, etc.; the present invention treats both manifestation and root causes of piles; piles have little possibility of relapse after being cured; the present invention has the advantages of conspicuous curative effect and no toxic or side effect; clinical symptoms of piles rapidly disappear. The present invention is suitable for treating internal piles, external piles, mixed piles, haemorrhoids and pain caused by stasis and swelling.
Description
The invention provides a kind of external-applied ointment for the treatment of hemorrhoid, belong to pure Chinese herbal and crude drugs preparations, relate to the technical field of pharmaceuticals of Chinese medicine hemorrhoid.
Hemorrhoid affect people's orthobiosis as people's commonly encountered diseases and frequently-occurring disease always, and the problem that runs at therapeutic process is: the course of disease is long, and state of an illness complexity is cured the symptoms, not the disease, obstinate, and outbreak brings very big misery to the patient repeatedly.
The object of the present invention is to provide a kind of external-applied ointment for the treatment of hemorrhoid, have treating both the principal and secondary aspects of a disease, cure the back and be difficult for characteristics such as recurrence.
Solution of the present invention is to be foundation with motherland's Chinese medicine to the pathogenesis and the Therapeutic Principle of hemorrhoid, utilization Chinese medical discrimination blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, the swollen bitterly method of dissipation, and selected pure Chinese herbal medicine in conjunction with the modern Chinese medicine processing procedure, is made external-applied ointment.
The present invention is the ointment of being made by ratio of weight and the number of copies by following Chinese herbal medicine:
Herba Taraxaci 4～8, Flos Carthami 4～10, Talcum 1～4, Olibanum 4～8, Radix Et Rhizoma Rhei 2～5,
Myrrha (processed) 5～9, eupolyphage sece steleophaga 1～3, Sanguis Draxonis 1～3, Radix Notoginseng 1～3, Borneolum Syntheticum 1～3.
Preferred weight portion rate of the present invention is:
Herba Taraxaci 6, Flos Carthami 7, Talcum 2, Olibanum 6, Radix Et Rhizoma Rhei 3, Myrrha (processed) 3,
Eupolyphage sece steleophaga 2, Sanguis Draxonis 2, Radix Notoginseng 2, Borneolum Syntheticum 2.
Production technology of the present invention is as follows: get above-mentioned raw materials decontamination, sterilization, be ground into 100～180 order fine powders, with 1 part of mediation of vaseline, filling bottle is packed behind the mix homogeneously.
Using method: external, coating affected part, every day 2～3 times.
Among the present invention with Herba Taraxaci heat-clearing and toxic substances removing, the carbuncle that dissipates, eliminate hard lump tuberculosis; Flos Carthami blood circulation promoting competent silt, inducing menstruation to relieve menalgia; Talcum removing damp-heat, treatment eczema, eczema; Olibanum blood circulation promoting regulates qi, pain relieving granulation promoting; The intestines and stomach stagnates and lets out, divides hot removing blood stasis, constipation with heat retention, stagnant carbuncle skin ulcer under the Radix Et Rhizoma Rhei.Assistant is controlled carbuncle skin infection, damage with the pain relieving of Myrrha removing blood stasis, detumescence and promoting granulation.Eupolyphage sece steleophaga, Sanguis Draxonis, Radix Notoginseng, Borneolum Syntheticum are strengthened removing blood stasis, are controlled the pain hemostasis, the convergence heat clearing away.All medicines are associated with mutually, play curative effect altogether.
Indication is internal hemorrhoid, external hemorrhoid, mixed hemorrhoid, blood stasis, swelling due to stasis.
Characteristics of the present invention are: pure Chinese herbal medicine is made, and has functions such as blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, dissipation be swollen bitterly, treating both the principal and secondary aspects of a disease, the recovery from illness back is difficult for recurrence, and evident in efficacy, clinical symptom disappearance is rapid, have no side effect, be applicable to the treatment of internal hemorrhoid, external hemorrhoid, mixed hemorrhoid, blood stasis, swelling due to stasis.
Therapeutic effect below in conjunction with clinical statement medicine of the present invention:
One, diagnostic criteria:
Be divided into internal hemorrhoid, external hemorrhoid, inside and outside mixed hemorrhoid, be divided into for three phases according to its evolution.
First phase: blood stasis is very little, and matter is soft, hemorrhoid are flushing or livid purple color, and is hemorrhage during often because of friction.
Second phase: blood stasis is bigger, can deviate from during stool outside the anus, recovers voluntarily after an action of the bowels, has blood in stool more or less.
Three phases: blood stasis is deviate from outside anus during stool, even also can occur deviating from when coughing, walking or standing for a long time, can not be from horizontal reset after deviating from.Blood stasis is hard, and the blood stasis piece is big, causes dyschesia, severe loss of blood, and deficiency of both QI and blood swells and ache, ulcer, downright bad suppuration secondary anal fistula.
Two, case is selected:
Select 147 routine clinical observations, male's 98 examples wherein, women's 49 examples, 16～30 years old age, 96 examples, 31～60 years old, 51 examples, first phase 40 examples, the second stage of 80 examples, three phases 27 examples; Matched group 128 examples are male's 59 examples wherein, and the women 69; Age 18-65 year, 48 years old mean age, first phase 45 examples, the second stage of 50 examples, three phases 33 examples.2 groups of cases are checked through t at aspects such as age, sex, the courses of disease, and difference does not have the significance meaning.
Include the case standard in: all suffer from internal hemorrhoid, external hemorrhoid, inside and outside mixed hemorrhoid, and the age, patient between 16～60 can include the object of observation in.
Three, grouping and comprehensive medication:
Case is selected first phase, second phase and three phase hemorrhoid patients by clinical manifestation, for the ease of the contrast of curative effect degree, the patient is divided into matched group and test group, test group use medicine of the present invention morning and evening every day each 1 time, 7 days is a course of treatment, and duration of test is forbidden other related drugs.Matched group is selected MAYINGLONGZHICHUANGGAO for use, and by its using method treatment.
Four, curative effect determinate standard:
Recovery from illness: cardinal symptom disappears.
Produce effects: cardinal symptom disappears more than 2/3.
Effectively: cardinal symptom alleviates.
Invalid: no change before and after the cardinal symptom treatment.
Five, clinical test results:
147 examples are organized in clinical total effects treatment, clinical cure 68 examples (46.3%), produce effects 42 examples (28.6%), effective 21 examples (14.3%), invalid 16 examples (10.8%), total effective rate 89.2%.Matched group 128 examples, clinical cure 31 examples (24.2%), produce effects 26 examples (20.3%), effective 19 examples (14.8%), invalid 52 examples (40.7%), total effective rate 59.3%.Two groups relatively, and the treatment group significantly is better than matched group.See the following form:
| Group | Clinical cure (%) | Produce effects (%) | Effectively (%) | Invalid (%) | Total effective rate (%) |
| Treatment group 147 | 68(46.3) | 42(28.6) | 21(14.3) | 16(10.8) | 89.2 |
| Matched group 128 | 31(24.2) | 26(20.3) | 19(14.8) | 52(40.7) | 59.3 |
Clinical trial proves that medicine of the present invention is obvious to the effect of system hemorrhoid, and stable lasting, recovery from illness and total effective rate all are better than matched group.
Case 1:
Certain man, 48 years old, suffer from hemorrhoid for many years, be diagnosed as first phase, blood stasis is very little, the matter softness, hemorrhoid color reddish violet, it is hemorrhage to rub during often because of stool, and drop is not felt pain, and blood stasis is not deviate from outside the anus.Apply medicine of the present invention cured on the 7th～10.
Case 2:
Certain woman, 52 years old, suffered from the second stage of hemorrhoid 6 years, blood stasis is bigger, can deviate from during stool outside the anus, recovers voluntarily after an action of the bowels, and is few for a long time when having blood in stool.After the demibain, coating is once fully recovered after 20 days every night, and drug withdrawal is not recurred later six months.
Case 3:
Certain man, 46 years old, look into three phase hemorrhoid, the blood stasis form is oval, the egg yolk size, blood stasis is deviate from outside the anus during stool, in the time of very in cough, walk or stand when of a specified duration, also can deviate from, can not recover voluntarily, very painful.Be coated with and use medicine of the present invention 3 months, clinical symptom disappearance is visited and was not had recurrence in 1 year.
Embodiment 1
Get Herba Taraxaci 6kg, Flos Carthami 7kg, Talcum 2kg, Olibanum 6kg, Radix Et Rhizoma Rhei 3kg, Myrrha (processed) 3kg, eupolyphage sece steleophaga 2kg, Sanguis Draxonis 2kg, Radix Notoginseng 2kg, Borneolum Syntheticum 2kg.Remove impurity, sterilization, be ground into 150 order fine powders, be in harmonious proportion with vaseline 1kg part behind the mix homogeneously, the filling bottle packing.
Claims (2)
1, a kind of external-applied ointment for the treatment of hemorrhoid is characterized in that its active component is made by the raw material of following portions by weight ratio:
Herba Taraxaci 4～8, Flos Carthami 4～10, Talcum 1～4, Olibanum 4～8, Radix Et Rhizoma Rhei 2～5,
Myrrha (processed) 5～9, eupolyphage sece steleophaga 1～3, Sanguis Draxonis 1～3, Radix Notoginseng 1～3, Borneolum Syntheticum 1～3.
2, the external-applied ointment of the described treatment hemorrhoid of claim 1 is characterized in that preparing used each the raw materials in part by weight ratio of its active component and is:
Herba Taraxaci 6, Flos Carthami 7, Talcum 2, Olibanum 6, Radix Et Rhizoma Rhei 3, Myrrha (processed) 3, eupolyphage sece steleophaga 2, Sanguis Draxonis 2, Radix Notoginseng 2, Borneolum Syntheticum 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN01114069A CN1120721C (en) | 2001-06-15 | 2001-06-15 | Exterior-applied ointment for treating piles |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN01114069A CN1120721C (en) | 2001-06-15 | 2001-06-15 | Exterior-applied ointment for treating piles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1327833A CN1327833A (en) | 2001-12-26 |
| CN1120721C true CN1120721C (en) | 2003-09-10 |
Family
ID=4660759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN01114069A Expired - Fee Related CN1120721C (en) | 2001-06-15 | 2001-06-15 | Exterior-applied ointment for treating piles |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1120721C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105193997A (en) * | 2015-10-26 | 2015-12-30 | 许玉泉 | Hemorrhoids ointment for external use |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102078385B (en) * | 2009-11-30 | 2013-08-28 | 威海新异生物科技有限公司 | External fig ointment |
| CN102451210A (en) * | 2010-11-03 | 2012-05-16 | 张守力 | Extraction method of effective ingredients from epimedium |
| CN103385996A (en) * | 2012-05-08 | 2013-11-13 | 闫淑珍 | Liquid pain killer and preparation method thereof |
| CN102727723B (en) * | 2012-06-26 | 2013-09-11 | 刘湘秋 | Traditional Chinese herbal rectal administration capsule for treating hemorrhoids |
| CN104491145B (en) * | 2014-12-04 | 2018-03-13 | 汲宗惠 | A kind of acne cream |
| CN111388598A (en) * | 2020-04-20 | 2020-07-10 | 陕西师范大学 | Traditional Chinese medicine preparation for treating haemorrhoids and preparation method thereof |
-
2001
- 2001-06-15 CN CN01114069A patent/CN1120721C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105193997A (en) * | 2015-10-26 | 2015-12-30 | 许玉泉 | Hemorrhoids ointment for external use |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1327833A (en) | 2001-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1739638A (en) | Medicine for treating dermatosis and its prepn | |
| CN1120721C (en) | Exterior-applied ointment for treating piles | |
| CN1289131C (en) | Traditional Chinese medicine for treating appendicitis with high efficiency | |
| CN1057697C (en) | Powder for curing ulcerative colitis and proctitis ulcerosa | |
| CN1183950C (en) | Chinese herbal medicine preparation for treating burns | |
| CN101530516B (en) | Chinese medicament for treating appendicitis | |
| CN1320451A (en) | Exterior-applied medicine for treating gynopathy | |
| CN1327831A (en) | Chinese medicine for treating tinea and antipruritic | |
| CN1180833C (en) | Chinese medicine against skin and external diseases | |
| CN1175847C (en) | Pile ointment | |
| CN1104246C (en) | Fumigant lotion for treating anorectal disease and preparing process thereof | |
| CN105233258A (en) | Composition for removing acne | |
| CN1879722A (en) | A medicine for treating rheumatic arthritis | |
| CN1066944C (en) | Ointment for burn and scald | |
| CN1270755C (en) | Pharmaceutical composition for treating rheumatic arthritis and rheumatoid arthritis | |
| CN1709477A (en) | Chinese medicine formulation for treating ance disease | |
| CN1279953C (en) | Mediciation for curing female disease | |
| CN108686102A (en) | A kind of Chinese medicine composition for treating gout | |
| CN1092519C (en) | Chinese medicine for argiitis | |
| CN1305510C (en) | Medicine for treating intractable fever | |
| CN1239180C (en) | Medicine for treating piles | |
| CN1052908C (en) | "Chanhouning" and its preparation method | |
| CN1171622C (en) | Medicine for treating dermatosis and its prepn | |
| CN1091011A (en) | A kind of lithodialysis Chinese traditional medicines depressing lipid electuary and manufacture method | |
| CN101983681A (en) | Medicament for treating abnormal leucorrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20030910 Termination date: 20120615 |